Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Protocol ID
ONC201-108
Disease (Sub Disease)
Diffuse Glioma
Diagnosis Stage
Newly diagnosed
Location
NSW, WA
Sponsor
Chimerix
Links
Trial Status
Open
Sites
Sydney Children's Hospital
Perth Children's Hospital
Perth Children's Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
Child, Adult, Older Adult
International registry ID's
NCT05580562
| Study Title | ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized Double-Blind Placebo-Controlled Multicenter Study |
|---|---|
| Protocol ID | ONC201-108 |
| Disease (Sub Disease) | Diffuse Glioma |
| Diagnosis Stage | Newly diagnosed |
| Location | NSW / WA |
| Sponsor | Chimerix |
| Links | https://clinicaltrials.gov/study/NCT05580562 |
| Trial Status | Open |
| Sites | Sydney Children's Hospital / Perth Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | Child, Adult, Older Adult |
| International registry ID's | NCT05580562 |